30 Years of Evidence
Join the experts’ corner
Featured Content
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy via Helical TomoTherapy versus Conventional Radiotherapy Combined with Concurrent Chemotherapy for Patients with Unresectable
Stage III NSCLC
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation
Repka MC, Aghdam N, Kataria SK, Campbell L, Suy S, Collins SP, Anderson E, Lischalk JW, Collins BT | Radiat Oncol. | 2017
Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy
Sharma A, Duijm M, Oomen-de Hoop E, Aerts JG, Verhoef C, Hoogeman M, Nuyttens JJ. | Acta Oncol | 2018
Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer
Sumodhee S, Bondiau PY, Poudenx M, Cohen C, Naghavi AO, Padovani B, Maneval D, Gal J, Leysalle A, Ghalloussi H, Otto J, Doyen J | BMC Cancer | 2019
A 54 Gy in three fractions of stereotactic body radiotherapy using CyberKnife for T1b-2aN0M0 pathologically confirmed non-small cell lung cancer
Abe T, Ryuno Y, Iino M, Saito S, Aoshika T, Ohta T, Igari M, Hirai R, Kumazaki Y, Kaira K, Kagamu H, Ishida H, Noda SE, Kato S | Jpn J Clin Oncol. | 2021
Fiducial markers for stereotactic lung radiation therapy: review of the transthoracic, endovascular and endobronchial approaches
Alessio Casutt, Rémy Kinj, Esat-Mahmut Ozsahin, Christophe von Garnier, Alban Lovis | Eur Respir Rev | 2022
Image-Guided Robotic Radiosurgery for the Treatment of Lung Metastases of Renal Cell Carcinoma-A Retrospective, Single Center Analysis
Severin Rodler, Melanie Götz, Jan-Niclas Mumm, Alexander Buchner, Annabel Graser, Jozefina Casuscelli, Christian Stief, Christoph Fürweger, Alexander Muacevic, Michael Staehler | Cancers (Basel) | 2022
Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer
Wang B, Dong Y, Yu X, Li F, Wang J, Chen H, Niu Z, Song Y, Yuan Z, Tao Z | Front Oncol | 2022
High-dose stereotactic body radiotherapy using CyberKnife® for stage I peripheral lung cancer: a single-center retrospective study
Ryuno Y, Abe T, Iino M, Saito S, Aoshika T, Oota T, Igari M, Hirai R, Kumazaki Y, Kaira K, Kagamu H, Ishida H, Noda SE, Kato S | Radiat Oncol | 2022